About Contact Us Careers
Sign In

Antibiotics Market - Top Companies and Manufacturers

  • Report ID: 4465
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Antibiotics Landscape

    • F. Hoffmann-La Roche Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • GlaxoSmithKline plc
    • Bristol-Myers Squibb Company
    • Teva Pharmaceuticals Industries Ltd.
    • Pfizer Inc.
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Lupin Limited
    • Melinta Therapeutics, LLC
    • Bayer AG  
Browse Key Market Insights with Data Illustration:

In the News

  • GlaxoSmithKline plc and Spero Therapeutics have announced an exclusive license agreement for tebipenem pivoxil hydrobromide (tebipenem HBr), a late-stage antibiotic that is anticipated to be used to treat complex urinary tract infections. Its 3rd phase clinical trial is estimated to start in 2023.

  • Teva Pharmaceuticals Industries Ltd. announced the launch of its 250 mg and 500 mg strength generic Erythromycin tablets as a therapeutic equivalent to Arbor Pharmaceuticals' reference listed drug (RLD) Erythromycin Tablets. A variety of bacterial infections and rheumatic fever attacks are projected to be treated with these tablets in patients allergic to penicillin.


Author Credits:  Radhika Pawar


  • Report ID: 4465
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of antibiotics is estimated at USD 53.91 billion.

The antibiotics market size was valued at USD 50.55 billion in 2024 and is expected to cross USD 142.07 billion by the end of 2037, expanding at more than 8.2% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of respiratory diseases, surge in drug combinations over mono-therapy, escalation in urinary tract infections (UTIs) will drive the market growth.

Asia Pacific is anticipated to hold majority industry share by 2037, backed by growing prevalence of infectious diseases, increasing consumption of antibiotics by regional population, significantly growing population, and growing healthcare expenditure in the region.

The major players in the market include F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., Lupin Limited, Melinta Therapeutics, LLC, Bayer AG.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample